Compare StocksMRNA vs TXN

Moderna, Inc. (MRNA) vs Texas Instruments Incorporated (TXN)

MRNA
Moderna, Inc.
$52.37
VS
TXN
Texas Instruments Incorporated
$188.29

Rewards

MRNA
    TXN
    • Texas Instruments Incorporated has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
    • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
    • Each dollar of retained earnings has created $3.91 of market value — management is an exceptional capital allocator.

    Risks

    MRNA
    • ROIC has declined by 61.0 percentage points over the observed period, which may signal competitive erosion.
    • Gross margin of -105.8% is low, suggesting a competitive or commodity-like market with limited pricing power.
    • Moderna, Inc. scores only 17/100 on the Economic Moat Score, suggesting limited durable competitive advantages.
    TXN
    • Trailing P/E of 34.6x is 28% above the historical average of 27.1x — the stock trades at a premium to its own history.
    • 7 insider sales totaling $26.5M with no purchases in the past 3 months — insiders are reducing their exposure.
    • Free cash flow has declined at a 24.0% CAGR over the past 4 years — a concerning trend.

    Key Valuation Metrics

    Learn more →
    MRNA
    TXN
    Valuation
    $-1.33B
    Free Cash Flow
    $-300.62M
    -6.41%
    FCF Yield
    -0.18%
    N/A
    Trailing P/E
    34.61
    -11.51
    Forward P/E
    23.81
    Quality & Moat
    -19.50%
    ROIC
    15.31%
    -32.62%
    ROE
    30.73%
    -105.76%
    Gross Margin
    57.02%
    N/A
    PEG Ratio
    N/A
    Balance Sheet Safety
    0.15
    Debt / Equity
    0.91
    N/A
    Interest Coverage
    N/A
    N/A
    Net Debt / EBITDA
    1.23
    N/A
    Dividend Yield
    3.02%
    MRNA: 2Ties: 1TXN: 5
    MRNATXN

    Historical Fundamentals

    Learn more →
    MRNA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

    TXN

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation.

    $1 Retained Earnings Test

    Learn more →
    MRNA
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-11.10B
    Δ Market Cap
    $-57.53B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    TXN
    $3.91
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $1.96B
    Δ Market Cap
    +$7.67B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    MRNA
    Insufficient Data
    Enter initial FCF to calculate intrinsic value
    Current Price: $52.37
    Fair Value: $0.00
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    TXN
    28.7% Margin of Safety
    Price is 28.7% below estimated fair value
    Current Price: $188.29
    Fair Value: $264.10
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    MRNA

    Requires positive FCF to compute implied growth rate.

    TXN

    Requires positive FCF to compute implied growth rate.

    Economic Moat Score

    Learn more →
    MRNA
    17/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable competitive advantage detected. The business shows limited evidence of pricing power, consistent returns, or capital efficiency.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    TXN
    48/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with roic consistency as the key competitive advantage. Improving reinvestment efficiency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    MRNA
    -3.72
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    TXN
    -2.67
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    MRNA
    Insiders 7.3%Institutions 77.1%Retail & Other 15.5%
    No. of Institutional Holders978
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    TXN
    Insiders 0.3%Institutions 91.3%Retail & Other 8.4%
    No. of Institutional Holders3,137
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    MRNA
    0
    Buys (3M)
    0
    Buys (12M)
    SAGAN PAUL L
    Director
    $1.00M
    @ $31.76 · 2025-03-03
    BANCEL STEPHANE J
    Chief Executive Officer
    $5.00M
    @ $31.22 · 2025-03-03
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    TXN
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    MRNA
    2
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $8.56M
    KLINGER SHANNON THYME
    Officer
    $726,047
    @ $52.29 · 2026-03-02
    HOGE STEPHEN
    President
    $7.81M
    @ $48.84 · 2026-02-23
    HUSSAIN SHAH ABBAS
    Director
    $13,910
    @ $27.60 · 2025-12-09
    HUSSAIN SHAH ABBAS
    Director
    $8,736
    @ $28.00 · 2025-06-11
    KLINGER SHANNON THYME
    Officer
    $23,637
    @ $44.68 · 2024-12-09
    HOGE STEPHEN
    President
    $13,595
    @ $43.30 · 2024-12-03
    KLINGER SHANNON THYME
    Officer
    $4,849
    @ $43.29 · 2024-12-03
    HOGE STEPHEN
    President
    $12,452
    @ $42.79 · 2024-11-29
    MOCK JAMES M
    Chief Financial Officer
    $60,761
    @ $42.79 · 2024-11-29
    KLINGER SHANNON THYME
    Officer
    $60,675
    @ $42.79 · 2024-11-29
    HOGE STEPHEN
    President
    $12,771
    @ $46.10 · 2024-11-11
    MOCK JAMES M
    Chief Financial Officer
    $42,986
    @ $60.12 · 2024-10-07
    KLINGER SHANNON THYME
    Officer
    $40,539
    @ $73.57 · 2024-09-09
    HOGE STEPHEN
    President
    $24,483
    @ $76.99 · 2024-09-03
    KLINGER SHANNON THYME
    Officer
    $8,777
    @ $76.99 · 2024-09-03
    HOGE STEPHEN
    President
    $23,408
    @ $78.03 · 2024-08-29
    MOCK JAMES M
    Chief Financial Officer
    $12,640
    @ $78.02 · 2024-08-29
    KLINGER SHANNON THYME
    Officer
    $12,640
    @ $78.02 · 2024-08-29
    MOCK JAMES M
    Chief Financial Officer
    $104,881
    @ $79.40 · 2024-08-28
    KLINGER SHANNON THYME
    Officer
    $104,722
    @ $79.39 · 2024-08-28
    HOGE STEPHEN
    President
    $21,363
    @ $84.11 · 2024-08-12
    AFEYAN NOUBAR BOGHOS
    Director
    $1.80M
    @ $119.96 · 2024-07-31
    AFEYAN NOUBAR BOGHOS
    Director
    $1.77M
    @ $117.80 · 2024-07-24
    AFEYAN NOUBAR BOGHOS
    Director
    $1.84M
    @ $122.84 · 2024-07-17
    HOGE STEPHEN
    President
    $1.82M
    @ $121.12 · 2024-07-15
    AFEYAN NOUBAR BOGHOS
    Director
    $1.76M
    @ $117.08 · 2024-07-10
    MOCK JAMES M
    Chief Financial Officer
    $81,465
    @ $118.24 · 2024-07-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.91M
    @ $127.22 · 2024-06-26
    AFEYAN NOUBAR BOGHOS
    Director
    $2.00M
    @ $133.57 · 2024-06-18
    HOGE STEPHEN
    President
    $2.07M
    @ $138.16 · 2024-06-17
    AFEYAN NOUBAR BOGHOS
    Director
    $2.21M
    @ $147.20 · 2024-06-12
    KLINGER SHANNON THYME
    Officer
    $766,785
    @ $148.09 · 2024-06-10
    AFEYAN NOUBAR BOGHOS
    Director
    $2.27M
    @ $151.25 · 2024-06-05
    HOGE STEPHEN
    President
    $47,704
    @ $140.72 · 2024-06-03
    MOCK JAMES M
    Chief Financial Officer
    $97,237
    @ $140.72 · 2024-06-03
    KLINGER SHANNON THYME
    Officer
    $17,168
    @ $140.72 · 2024-06-03
    AFEYAN NOUBAR BOGHOS
    Director
    $2.90M
    @ $145.08 · 2024-05-29
    HOGE STEPHEN
    President
    $49,276
    @ $144.50 · 2024-05-29
    MOCK JAMES M
    Chief Financial Officer
    $26,444
    @ $144.50 · 2024-05-29
    KLINGER SHANNON THYME
    Officer
    $26,444
    @ $144.50 · 2024-05-29
    MOCK JAMES M
    Chief Financial Officer
    $105,283
    @ $162.47 · 2024-05-28
    KLINGER SHANNON THYME
    Officer
    $210,566
    @ $162.47 · 2024-05-28
    AFEYAN NOUBAR BOGHOS
    Director
    $2.36M
    @ $157.57 · 2024-05-22
    AFEYAN NOUBAR BOGHOS
    Director
    $1.91M
    @ $127.32 · 2024-05-15
    HOGE STEPHEN
    President
    $1.91M
    @ $127.49 · 2024-05-15
    HOGE STEPHEN
    President
    $30,844
    @ $120.96 · 2024-05-10
    AFEYAN NOUBAR BOGHOS
    Director
    $1.83M
    @ $121.68 · 2024-05-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.66M
    @ $110.92 · 2024-05-01
    AFEYAN NOUBAR BOGHOS
    Director
    $1.62M
    @ $108.32 · 2024-04-24
    AFEYAN NOUBAR BOGHOS
    Director
    $1.55M
    @ $103.38 · 2024-04-17
    HOGE STEPHEN
    President
    $1.58M
    @ $105.02 · 2024-04-15
    AFEYAN NOUBAR BOGHOS
    Director
    $1.61M
    @ $107.12 · 2024-04-10
    MOCK JAMES M
    Chief Financial Officer
    $71,859
    @ $101.93 · 2024-04-08
    AFEYAN NOUBAR BOGHOS
    Director
    $1.53M
    @ $101.68 · 2024-04-03
    AFEYAN NOUBAR BOGHOS
    Director
    $1.64M
    @ $109.06 · 2024-03-27
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    TXN
    7
    Sells (3M)
    10
    Sells (12M)
    Total value (12M): $28.61M
    KOZANIAN HAGOP H
    Officer
    $1.55M
    @ $225.95 · 2026-02-17
    LIZARDI RAFAEL R
    Chief Financial Officer
    $15.88M
    @ $221.73 · 2026-02-11
    GARY MARK
    Officer
    $5.24M
    @ $226.00 · 2026-02-11
    BAHAI AHMAD
    Officer
    $1.50M
    @ $230.79 · 2026-02-11
    ROBERTS MARK T
    Officer
    $986,604
    @ $221.16 · 2026-02-09
    BLINN MARK A
    Director
    $696,647
    @ $221.58 · 2026-02-05
    BAHAI AHMAD
    Officer
    $670,387
    @ $223.46 · 2026-02-05
    KIRK RONALD
    Director
    $1.62M
    @ $162.33 · 2025-11-24
    WITZSCHE CHRISTINE
    Officer
    $164,306
    @ $164.31 · 2025-11-13
    BAHAI AHMAD
    Officer
    $308,030
    @ $205.35 · 2025-08-25
    TEMPLETON RICHARD K
    Chairman of the Board
    $19.85M
    @ $195.41 · 2025-02-28
    TEMPLETON RICHARD K
    Chairman of the Board
    $38.65M
    @ $199.20 · 2025-02-26
    TEMPLETON RICHARD K
    Chairman of the Board
    $39.32M
    @ $202.70 · 2025-02-24
    CLARK JANET F
    Director
    $1.23M
    @ $203.62 · 2025-02-24
    BLINN MARK A
    Director
    $1.17M
    @ $189.89 · 2025-02-19
    LEONARD SHANON J
    Officer
    $401,241
    @ $186.62 · 2025-02-18
    BLINN MARK A
    Director
    $106,617
    @ $180.71 · 2025-02-04
    KIRK RONALD
    Director
    $2.14M
    @ $203.33 · 2024-11-25
    GARY MARK
    Officer
    $3.49M
    @ $219.82 · 2024-11-08
    ILAN HAVIV
    Chief Executive Officer
    $2.88M
    @ $219.30 · 2024-11-08
    LIZARDI RAFAEL R
    Chief Financial Officer
    $10.19M
    @ $217.16 · 2024-11-07
    YUNUS MOHAMMAD
    Officer
    $1.81M
    @ $216.94 · 2024-11-07
    BAHAI AHMAD
    Officer
    $472,514
    @ $217.25 · 2024-11-07
    GARY MARK
    Officer
    $940,296
    @ $214.83 · 2024-11-06
    WITZSCHE CHRISTINE
    Officer
    $27,941
    @ $211.67 · 2024-11-06
    ILAN HAVIV
    Chief Executive Officer
    $5.29M
    @ $211.50 · 2024-11-06
    SANCHEZ ROBERT E
    Director
    $2.09M
    @ $208.80 · 2024-10-25
    RON AMICHAI
    Officer
    $2.76M
    @ $213.72 · 2024-08-29
    GARY MARK
    Officer
    $3.22M
    @ $212.63 · 2024-08-29
    ROBERTS MARK T
    Officer
    $1.00M
    @ $213.08 · 2024-08-29
    PATSLEY PAMELA H
    Director
    $1.29M
    @ $212.43 · 2024-08-29
    BAHAI AHMAD
    Officer
    $892,427
    @ $209.98 · 2024-08-27
    ILAN HAVIV
    Chief Executive Officer
    $251,324
    @ $209.44 · 2024-08-26
    YUNUS MOHAMMAD
    Officer
    $789,215
    @ $208.90 · 2024-08-26
    GARY MARK
    Officer
    $939,037
    @ $207.20 · 2024-08-23
    KNECHT JULIE C.
    Officer
    $1.63M
    @ $209.49 · 2024-08-23
    LEONARD SHANON J
    Officer
    $588,301
    @ $208.91 · 2024-08-23
    HOBBY JEAN M
    Director
    $4.37M
    @ $205.71 · 2024-08-22
    TEMPLETON RICHARD K
    Chairman of the Board
    $17.93M
    @ $178.47 · 2024-05-03
    TEMPLETON RICHARD K
    Chairman of the Board
    $36.53M
    @ $175.64 · 2024-05-02
    SANCHEZ ROBERT E
    Director
    $1.84M
    @ $174.97 · 2024-05-01
    TEMPLETON RICHARD K
    Chairman of the Board
    $37.09M
    @ $178.34 · 2024-04-30
    PATSLEY PAMELA H
    Director
    $1.79M
    @ $179.12 · 2024-04-29
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    MRNA
    FearGreed
    😐Neutral(47/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    TXN
    FearGreed
    😐Neutral(46/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    MRNA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
    TXN
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (46)
    View MRNA Full AnalysisView TXN Full Analysis